PRNewsWire
29 Apr 2026, 10:50 UTC · 20w ago
Verdict
Headline takes no side. We score BDX +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company launched a first-of-its-kind insertion system that received FDA clearance and expands its market presence in acute CVC.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2d ago
+21.0%
Price agrees with the score
$180.94 vs $149.52 close before publication (Apr 28) · not market-adjusted
BDX chart →
